← Back to Search

Omega-3 Nutritional Supplement

Omega-3 for Cataract

Phase 2 & 3
Waitlist Available
Led By Bradley Williams, MD
Research Sponsored by Physician Recommended Nutriceuticals
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 weeks
Awards & highlights

Study Summary

This is a randomized, masked, placebo controlled study to assess the effect on visual acuity, if any, of the PRN omega-3 nutritional supplement in subjects undergoing cataract surgery.

Eligible Conditions
  • Cataract

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 8 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Visual Acuity

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Omega-3Active Control1 Intervention
re esterified TG omega-3
Group II: Safflower OilPlacebo Group1 Intervention
vegetable oil

Find a Location

Who is running the clinical trial?

Physician Recommended NutriceuticalsLead Sponsor
4 Previous Clinical Trials
292 Total Patients Enrolled
Bradley Williams, MDPrincipal InvestigatorSouthern Eye Associates
1 Previous Clinical Trials
2 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~14 spots leftby Apr 2025